Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The rapid rise in GLP-1 medication use has redefined consumers food expectations, panelists shared in a Tuesday IFT FIRST Hot Topics Studio session titled GLP-1 and the Future of Food: Formulating for New Consumer Reality. As consumers eat less, they want their food to do more
This is achieved with a dosage that reduces appetite enough for gradual weight loss, but still keeps the patient's hunger and fullness signals
A very large portion of the adult population could potentially meet clinical criteria for these drugs, which makes it imperative for plan sponsors to think strategically not reactively about how they are managed
The compounded Semaglutide has been arranged and you can start today
